Gordon Moody

Gordon Moody is a seasoned professional in the field of immuno-oncology and drug development, currently serving as Senior Director of Research Cell Therapy at AstraZeneca since February 2020. Prior experience includes roles as Senior Scientist at MedImmune, focusing on immuno-oncology research, and nearly 12 years at Amgen, where contributions spanned oncology drug discovery, novel in vivo platform design, and the development of pharmacodynamic assays. Earlier career positions include roles at MedImmune and Human Genome Sciences, where the emphasis was on cancer pharmacology and genomics-based drug discovery. Gordon Moody holds a Master's degree in Biotechnology from The Johns Hopkins University and a Bachelor's degree in Biology from William & Mary.